meta_pixel
Tapesearch Logo
Log in
The Josh Marshall Podcast

SCOTUS Doesn't Do The Terrible Thing For Once

The Josh Marshall Podcast

Talking Points Memo

Unknown

4.91.8K Ratings

🗓️ 13 June 2024

⏱️ 39 minutes

🧾️ Download transcript

Summary

Josh and Kate convene for an insta-pod on the Supreme Court's major mifepristone decision.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Transcript

Click on a timestamp to play from that location

0:00.0

Hi dear listeners, this is Kate Riga. I'm here to make a quick pitch that you consider becoming a TPM Prime member.

0:06.3

TPM has used the member model for over a decade now and our loyal members are the only reason we've been able to weather the turbulence of the media

0:13.3

landscape and avoid the fate that has befallen so many other independent outlets.

0:17.2

For $70 you get no paywall, fewer ads, access to the Hive Member Forum, a

0:22.4

members only newsletter, and more.

0:24.6

For $140 a year, you get all of that, plus no ads at all.

0:28.8

Without our members, there is no podcast.

0:31.2

Not to mention that I'm out of a job.

0:33.2

Thank you so much for listening and supporting us.

0:36.1

We couldn't do it without you. Oh, Hi this is the Josh Marshall podcast featuring Kate Rika. Today we have an

1:04.1

insta pod right on the breaking news. We had a big court case come down this

1:09.6

morning, not totally unexpected results but maybe some surprise in the unanimity and the sort of the, you know, the kind of the absoluteness of the decision, for lack of a better word.

1:20.3

So, and it's also a case that we have been following very closely and we in the sense of Kate so

1:26.9

Kate what happened? So today we got our case on Miffa Pristone. This was the one where this group of anti-abortion

1:38.1

doctors is kind of like hastily cobbled together association that was formed in Amarillo, Texas, right after Dobbs, with the pretty,

1:47.6

you know, express intent to plant this lawsuit with Kasmaric and go through the Fifth Circuit, this pipeline we've seen before and we've talked a lot about on the pod.

1:55.9

They're seeking to get Mifopristone yanked from the market altogether to get its FDA approval revoked, but short of that to reimpose all these restrictions

2:06.0

that the agency has lifted in recent years a lot of which kind of go

2:09.7

towards the convenience of getting the medication.

2:13.0

So allowing it to be dispensed at pharmacies

2:15.8

and not just clinics, letting it be mailed,

2:20.0

all that kind of stuff.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Talking Points Memo, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Talking Points Memo and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.